Carlyle Group INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SCHEDULE: Carlyle Group Adjusts SunPower Stake
Carlyle Group entities report a change in beneficial ownership of SunPower Inc. common stock, now holding 4.4% of the outstanding shares.
NASDAQ
The Carlyle Group and its affiliates have reported beneficial ownership of 4.1% of Q32 Bio Inc.'s common stock as of June 18, 2026.
NASDAQ
The Carlyle Group and its affiliates have filed a Schedule 13G reporting a 20.6% beneficial ownership stake in Medline Inc. Class A Common Stock.
NASDAQ
The Carlyle Group has filed an amended Schedule 13G, confirming its continued beneficial ownership of 84,587,035 shares of StandardAero, Inc. common stock.
NASDAQ
Capital World Investors has reported a 5.0% beneficial ownership of The Carlyle Group Inc. common stock as of March 31, 2026.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting a 0% beneficial ownership in Carlyle Group Inc. following an internal realignment.
NASDAQ
Carlyle Group Inc. and its affiliates have reported a beneficial ownership of 24.4% of Medline Inc.'s Class A Common Stock as of December 31, 2025.
NASDAQ
The Carlyle Group Inc. and its affiliates have reported an 8.1% beneficial ownership stake in SunPower Inc., totaling 7,211,351 shares.
NASDAQ
Carlyle Group and its affiliates reported their beneficial ownership in Phathom Pharmaceuticals, Inc. has fallen to 4.9% due to dilution from the issuer's stock issuances.
NASDAQ
Capital World Investors has disclosed a 5.6% beneficial ownership stake in The Carlyle Group Inc., holding over 20 million shares.
NASDAQ
SCHEDULE: Carlyle Group Amends StandardAero Stake
Carlyle Group Inc. and its affiliates have filed an amended Schedule 13G, reporting continued beneficial ownership of 45.6% of StandardAero, Inc.'s common stock.
NASDAQ
The Carlyle Group and its affiliates have filed an amended Schedule 13G, indicating they no longer hold any beneficial ownership in Black Stone Minerals, L.P. as of March 31, 2025.
NASDAQ
SCHEDULE 13G/A: Carlyle Group Affiliates Reaffirm Majority Stake in StandardAero, Inc. with 54.1% Ownership
Carlyle Group Inc. and its affiliated entities have filed an amended Schedule 13G, confirming their beneficial ownership of 54.1% of StandardAero, Inc.'s common stock.
NASDAQ
Capital World Investors has filed an amended Schedule 13G, reporting a 4.9% beneficial ownership stake in The Carlyle Group Inc. as of March 31, 2025.
NASDAQ
SCHEDULE 13G/A: David M. Rubenstein Consolidates Control Over Carlyle Group Shares Following Proxy Expiration
Carlyle Group co-founder David M. Rubenstein has gained sole voting and dispositive power over his 8.1% stake in the company following the expiration of a previously granted irrevocable proxy.
NASDAQ
SCHEDULE 13G/A: Daniel A. D'Aniello Reports 9.0% Stake in Carlyle Group, Regains Sole Voting Power as Proxy Expires
Daniel A. D'Aniello has reported a 9.0% beneficial ownership stake in The Carlyle Group Inc., with his previously granted irrevocable proxy expiring on January 1, 2025, shifting sole voting power to him.
NASDAQ
SCHEDULE 13G/A: William E. Conway Jr. Discloses 8.3% Stake in Carlyle Group, Proxy Agreement Expires
William E. Conway Jr., a co-founder of The Carlyle Group Inc., has filed an amended Schedule 13G disclosing beneficial ownership of 8.3% of the company's common stock, noting the expiration of a significant proxy agreement.
NASDAQ
The Carlyle Group Inc. and its affiliates have filed a Schedule 13G, revealing a beneficial ownership of 210,190,466 shares, representing 62.8% of StandardAero, Inc.'s common stock as of December 31, 2024.